Skip to main content

Table 1 Profile of subjects

From: Improvement of the fraction of human mercaptalbumin on hemodialysis treatment using hydrogen-dissolved hemodialysis fluid: a prospective observational study

 

Median (min − max)

 

EW-HDa

C-HD

Healthy subjects

Gender (M/F)

6/6

24/14

11/13

Age (years old)

70 (57–83)

73 (37–89)

39 (21–54)

Primary disease (DM/non-DM)

6/6

14/24

Body weight at post-HD (kg)

48.7(43.7–64.7)

53.3 (33.3–87.5)

HD treatment time (hours)

4.0 (3.5–4.0)

4.0 (3.0–5.0)

HD vintage (months)

8 (1–150)

22 (2–128)

EW-HD vintage (days)

75 (19–210)

  1. There was no significant difference between EW-HD and C-HD
  2. aAt 2014